Top

Published in:

Open Access 01-12-2015 | Case Report

Intrauterine Treatment of a Fetus with Familial Hypertrophic Cardiomyopathy Secondary to MYH7 Mutation

Authors: Meghan G. Hill, MBBS, Mehtab K. Sekhon, MD, Kathryn L. Reed, MD, Caroline F. Anderson, RDMS, Nydia D. Borjon, BS RDMS, Jil C. Tardiff, MD PhD, Brent J. Barber, MD

Published in: Pediatric Cardiology | Issue 8/2015

Abstract

There is no clear consensus on optimal management of fetuses affected by familial hypertrophic cardiomyopathy (HCM). Intrauterine treatment of the condition has not been attempted in any standardized fashion. We report the case of a fetus treated by maternal propranolol during the third trimester after septal hypertrophy and diastolic dysfunction was diagnosed on fetal echocardiogram. The pregnancy went successfully to term, and fetal septal hypertrophy was noted to improve prior to delivery.

Bourmayan C, Razavi A, Fournier C et al (1985) Effect of propranolol on left ventricular relaxation in hypertrophic cardiomyopathy: an echographic study. Am Heart J 109(6):1311–1316CrossRefPubMed

Gersh BJ, Maron BJ, Bonow RO et al (2011) 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 124(24):2761–2796CrossRefPubMed

Goldberg BB, McGahan JP (2006) Atlas of ultrasound measurements, 2nd edn. Mosby, Elsevier, Philadelphia, PA

Hecher K, Campbell S, Snijders R, Nicolaides K (1994) Reference ranges for fetal venous and atrioventricular blood flow parameters. Ultrasound Obstet Gynecol 4(5):381–390CrossRefPubMed

Hinton RB, Michelfelder EC, Marino BS, Bove KE, Ware SM (2010) A fetus with hypertrophic cardiomyopathy, restrictive, and single-ventricle physiology, and a beta-myosin heavy chain mutation. J Pediatr 157(1):164–166PubMedCentralCrossRefPubMed

Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE (1995) Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation 92(4):785–789CrossRefPubMed

Maron BJ, Maron MS, Semsarian C (2012) Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives. J Am Coll Cardiol 60(8):705–715CrossRefPubMed

Ostman-Smith I, Wettrell G, Riesenfeld T. A (1999) Cohort study of childhood hypertrophic cardiomyopathy: improved survival following high-dose beta-adrenoceptor antagonist treatment. J Am Coll Cardiol 34(6):1813–1822CrossRefPubMed

Pedra SR, Smallhorn JF, Ryan G et al (2002) Fetal cardiomyopathies: pathogenic mechanisms, hemodynamic findings, and clinical outcome. Circulation 106(5):585–591CrossRefPubMed

10.

Veille JC, Sivakoff M, Hanson R, Fanaroff AA (1992) Interventricular septal thickness in fetuses of diabetic mothers. Obstet Gynecol 79(1):51–54PubMed

11.

Zielinsky P (1991) Role of prenatal echocardiography in the study of hypertrophic cardiomyopathy in the fetus. Echocardiography 8(6):661–668CrossRefPubMed

Title: Intrauterine Treatment of a Fetus with Familial Hypertrophic Cardiomyopathy Secondary to MYH7 Mutation
Authors: Meghan G. Hill, MBBS
Mehtab K. Sekhon, MD
Kathryn L. Reed, MD
Caroline F. Anderson, RDMS
Nydia D. Borjon, BS RDMS
Jil C. Tardiff, MD PhD
Brent J. Barber, MD
Publication date: 01-12-2015
Publisher: Springer US
Published in: Pediatric Cardiology / Issue 8/2015
Print ISSN: 0172-0643
Electronic ISSN: 1432-1971
DOI: https://doi.org/10.1007/s00246-015-1250-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Intrauterine Treatment of a Fetus with Familial Hypertrophic Cardiomyopathy Secondary to MYH7 Mutation

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 8/2015

Recombinant Tissue Plasminogen Activator in the Treatment of Neonates with Intracardiac and Great Vessels Thrombosis

Outcomes of Patients After Arterial Switch Operation: 18 Years of Experience in a Single Medium-Volume Center

Left Ventricular Non-compaction: Is It Genetic?

Identification of Copy Number Variations in Isolated Tetralogy of Fallot

Timing of Dynamic NT-proBNP and hs-cTnT Response to Exercise Challenge in Asymptomatic Children with Moderate Aortic Valve Regurgitation or Moderate Aortic Valve Stenosis

Staged Biventricular Repair-Oriented Strategy in Borderline Biventricular Repair Candidates with Ventricular Septal Defect